Search for a report

EUROPE MEDICAL ENZYMES MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • EUROPE MEDICAL ENZYMES MARKET FORECAST 2022-2030

EUROPE MEDICAL ENZYMES MARKET FORECAST 2022-2030

The Europe medical enzymes market is anticipated to record a CAGR of 5.86% across the estimated period of 2022 to 2030, capturing a revenue share of $1992.82 million by 2030.

EUROPE MEDICAL ENZYMES MARKET FORECAST 2022-2030

Europe Medical Enzymes Market by Type (Hydrolase (Hyaluronidase, Lysozymes, Other Hydrolases Enzymes), Thrombolytic (Streptokinase, Urokinase, Other Thrombolytic Enzymes), Digestive Enzyme (Lactase, L-asparaginase, Other Digestive Enzymes), Endonuclease (Benzonase, Other Endonucleases)) Market by Application ( Disease Treatment, Diagnostic Tools, Biomedical Research, Other Applications)

Request free sample

The Europe medical enzymes market is anticipated to record a CAGR of 5.86% across the estimated period of 2022 to 2030, capturing a revenue share of $1992.82 million by 2030.

Some of the top drivers augmenting the market growth of the region include the increasing demand for enzymes in the pharmaceutical sector, the growing need for nutraceuticals and dietary supplements following the COVID-19 pandemic, and the rise in research and development activities. However, the Europe medical enzymes market growth is likely to be restrained by regulatory norms associated with the European Union.

Europe Medical Enzymes Market

To know more about this report, request a free sample copy

The Europe medical enzymes market growth study entails the assessment of the United Kingdom, Germany, France, Poland, Belgium, Italy, and Rest of Europe. The rise in health awareness is one of the key reasons for the growth of the medical enzymes market in the United Kingdom. The nation offers healthcare to all permanent residents in accordance with the National Health Service. Moreover, it is estimated that the annual real gross domestic product (GDP) will grow by nearly 4.7% in 2022, as per the International Monetary Fund (IMF). The public sector investment in research and development in the United Kingdom is also sanctioned to increase to $26 billion by 2024-2025.

The United Kingdom recorded nearly 375,400 cases of cancer from 2016 to 2018, and this figure is expected to rise further over the upcoming years. Moreover, since cardiovascular disease is one of the major causes of death in the country, the demand for medical enzymes is anticipated to increase during the forecast period.

Likewise, cardiovascular disease and cancer are among the leading causes of death in Germany. In addition, obesity is also a growing concern in the country. In this regard, in vitro diagnostics (IVD) devices are used for the detection of such diseases, including infections and gastrointestinal diseases, primarily for early diagnosis and treatment. Hence, these factors are evaluated to accelerate the medical enzymes market growth in Europe during the forecast period.

The Europe medical enzymes market is segmented into type and application. The application category is further segmented into diagnostic tools, biomedical research, disease treatment, and other applications. Since enzymes are specific biological catalysts, they are utilized as therapeutic agents for treating metabolic diseases. Besides, enzymes are also used to dissolve the hardening walls of blood vessels, reduce wound swelling, and break internal blood clots.

On the other hand, enzymes are also used in the diagnosis of diseases. In this regard, enzymes offer insights into numerous ailments through the assessment, prognosis, as well as diagnosis of the response therapy. Likewise, enzyme biosensors can also be utilized as an analytical tool for diagnosing different disorders.

The top companies operating in the Europe medical enzymes market are Sanofi, BASF, BBI Solutions, etc.

Sanofi, headquartered in France, is a major healthcare company operating in nearly 100 countries. It also has 20 research and development facilities, in addition to 70 manufacturing sites. The company’s business can be classified into vaccines, specialty care, and general medicines. Moreover, Sanofi’s operating segments include oncology, blood disorders, immunology, diabetes, neurology, cardiovascular diseases, and others.

The company’s product Nirsevimab primarily helps prevent the respiratory syncytial virus, with an acute focus on the protection of infants.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Type and Application
Countries Analyzed The United Kingdom, Germany, France, Poland, Belgium, Italy, and Rest of Europe.
Companies Analyzed

BASF, DuPont, Roche Holding, Novozymes, DSM, Sanofi, Codexis, Novus, BRAIN, Sekisui, Advanced Enzymes, Amano Enzyme, BBI Solutions, Thermo Fisher Scientific, CPC Biotech

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
        • WIDENING APPLICATION IN MEDICAL INDUSTRY
        • GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
      • KEY RESTRAINTS
        • HANDLING AND SAFETY OF ENZYMES
        • REGULATIONS FOR MEDICAL ENZYMES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
        • RESEARCH AND DEVELOPMENT
        • OPERATIONS
        • OUTBOUND LOGISTICS
      • KEY BUYING CRITERIA
        • COST
        • QUALITY
        • APPLICATION
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS
    2. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ADVANCED ENZYMES
        • AMANO ENZYME
        • BASF
        • BBI SOLUTIONS
        • BRAIN
        • CODEXIS
        • CPC BIOTECH
        • DSM
        • DUPONT
        • NOVOZYMES
        • NOVUS
        • ROCHE
        • SANOFI
        • SEKISUI
        • THERMO FISHER SCIENTIFIC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – MEDICAL ENZYMES

    TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES

    TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY

    TABLE 4: REGULATORY FRAMEWORK

    TABLE 5: EUROPE MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6: EUROPE MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 14: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 15: EUROPE MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 16: EUROPE MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 17: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 18: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 19: LEADING PLAYERS OPERATING IN EUROPE MEDICAL ENZYMES MARKET

    TABLE 20: LIST OF MERGERS & ACQUISITIONS

    TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES          

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 8: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)

    FIGURE 9: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021

    FIGURE 10: EUROPE MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)

    FIGURE 11: EUROPE MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 12: EUROPE MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 13: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 14: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021

    FIGURE 15: EUROPE MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)

    FIGURE 16: EUROPE MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)

    FIGURE 17: EUROPE MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 18: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)

    FIGURE 19: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021

    FIGURE 20: EUROPE MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)

    FIGURE 21: EUROPE MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)

    FIGURE 22: EUROPE MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 23: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)

    FIGURE 24: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021

    FIGURE 25: EUROPE MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)

    FIGURE 26: EUROPE MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)

    FIGURE 27: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 28: EUROPE MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)

    FIGURE 29: EUROPE MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)

    FIGURE 30: EUROPE MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)

    FIGURE 31: EUROPE MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 32: EUROPE MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 33: UNITED KINGDOM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 34: GERMANY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 35: FRANCE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 36: ITALY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 37: BELGIUM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 38: POLAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 39: REST OF EUROPE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now